Klinik Araştırma
BibTex RIS Kaynak Göster

Pediyatrik Palyatif Bakım Ünitesindeki Enfeksiyon Ajanlarının Değerlendirilmesi

Yıl 2024, Cilt: 3 Sayı: 4, 152 - 160, 20.12.2024
https://doi.org/10.57221/izmirtip.1494548

Öz

Amaç: Geniş spektrumlu antibiyotiklerin kullanımı, hasta profilindeki değişiklikler, yaşam süresinin uzaması, kateterler, damar içi sıvılar, gastrostomi ve trakeostomi gibi tıbbi cihaz ve teknoloji kullanımının artması enfeksiyonlar ve kültürlerden izole edilen mikroorganizmaların sayısında ve türünde değişikliğe neden olmuştur. Pediyatrik palyatif bakımda görülen enfeksiyonlara dair veri bulunmamaktadır. Bu çalışmada amaç enfeksiyon sıklığını ve kültürde üretilen patojenleri saptamak, üreme yerlerini bulmak ve yapılması gerekenleri gözden geçirmektir.
Yöntem: Çalışma 18.11.2018-01.09.2023 tarihleri arasında kesitsel, retrospektif bir çalışma olarak planlandı. Sosyodemografik veriler, yatış nedeni, yatış sayısı, primer tanıları, komorbid durumları, kullandıkları tıbbi cihaz ve teknoloji, kültür alınma yeri ve zamanı, kültür sayısı, üreyen mikroorganizmalar ve kültür üremesiyle ilişkili faktörler incelendi. İstatistiksel analiz SPSS 18.0 prog¬ramı ile yapıldı. p<0,05 değeri anlamlı kabul edildi. Yerel etik kurul onayı alındı (14/09/2023-176).
Bulgular: toplam 414 hastadan 218’i çalışmaya dahil edildi. 392 yatıştan alınan 1209 kültür tetkiki değerlendirildi. Yaş ortalaması=5,68±5,33 (SD) yıl, %56,9’u (n=124) erkekti. Yatış nedeni enfeksiyon ve enfeksiyon dışı olarak gruplandırıldığında kültür üremesi açısından fark saptanmadı (p=0,778). Medikal komorbiditeler ile kültür üremesi arasında anlamlı fark saptandı (p=0,008) ve Post hoc analizi ile değerlendirildiğinde kardiovasküler hastalıklar ve konjenital hastalıklar ile ilişkili anlamlı fark bulundu (sırasıyla p=0,001 ve p=0,018).
Sonuç: Bu sonuçlar, pediyatrik palyatif bakımdaki ilk veriler olup yaklaşık yarısında kültürde üreme olduğunu, kardiovasküler sistem hastalıkları ve konjenital hastalıklarla ilişkili olduğunu göstermiştir. Uzun süreli tedavi ve izlem gerektiren hasta profilimiz için aile eğitiminin, bakım ve enfeksiyonların önlenmesine yönelik eğitimlerin belirli aralarla tekrarlanmasının enfeksiyon sıklığını düşürebilir.

Kaynakça

  • 1. Ergul AB, Isık H, Altıntop YA, Torun YA. A retrospective evaluation of blood cultures in a pediatric intensive care unit: a three year evaluation. Turk Pediatri Ars. 2017;52:154-61.
  • 2. Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001;7:188-92.
  • 3. Gulmez D, Gur D. Microorganisms isolated from blood cultures in Hacettepe University Ihsan Dogramacı children’s hospital from 2000 to 2011: Evaluation of 12 Years. J Pediatr Inf. 2012;6:79-83.
  • 4. Saglam D, Ercal BD, Yagmur G, Oz HT, Akin MA, Berk E. Distribution of microorganisms isolated from blood cultures collected from the neonatal intensive care units of Kayseri training and research hospital. Abant Med J. 2015;4:255-60.
  • 5. Celiloglu C, Tolunay O, Celik T, Sucu T, Yurtcu E, Celik E. Assessment of healthcare-associated infections in the pediatric intensive care unit. J Pediatr Inf. 2017;11:129-34.
  • 6. Adamuz J, Viasus D, Camprecios-Rodriguez P, Canavate-Jurado O, Jimenez-Martinez E, Isla P, et al. A prospective cohort study of healthcare visits and rehospitalizations after discharge of patients with community-acquired pneumonia. Respirology. 2011;16:1119-26.
  • 7. Markham JL, Hall M, Goldman JL, Bettenhausen JL, Gay JC, Feinstein J, et al. Readmissions following hospitalization for infection in children with or without medical complexity. Journal of Hospital Medicine. 2021;16:134-41.
  • 8. Cetin S, Celik I, Artan C. Evaluation of microorganisms and antibiotic resistance profile isolated in intensive care unit patients. Turk J Intensive Care. 2021;19:9-17.
  • 9. Bayram A, Balci I. Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey. BMC Infect Dis. 2006;6:155.
  • 10. Erturk A, Copur C, Koksal E, Koksal Z, Ozyurt S. Microorganisms isolated from various clinical samples and their antibiotic susceptibilities in intensive care unit patients. ANKEM Derg. 2012;26:1-9.
  • 11. Atici S, Soysal A, Kadayifci KE, Karaaslan A, Akkoc G, Yakut N, et al. Healthcare-associated infections in a newly opened pediatric intensive care unit in Turkey: results of four-year surveillance. J Infect Dev Ctries. 2016;10:254-9.
  • 12. Aktar F, Tekin R, Gunes A, Ulgen C, Tan I, Ertugrul S, et al. Determining the independent risk factors and mortality rate of nosocomial infections in pediatric patients. Biomed Res Int. 2016; 7240864.
  • 13. Lopez AP, Ladhani SN, Breathnach A, Planche T, Helath PT. Trends in paediatric nosocomial bacteraemia in a London tertiary hospital. Acta Paediatr. 2013;102:1005-9.
  • 14. Wienecke LM, Cohen S, Bauersachs J, Mebazaa A, Chousterman BG. Immunity and inflammation: the neglected key players in congenital heart disease? Heart Fail Rew. 2022;27:1957-71.
  • 15. Furlong-Dillard J, Bailly D, Amula V, Wilkes J, Bratton S. Resource use and morbidities in pediatric cardiac surgery patients with genetic conditions. J Pediatr. 2018;193:139-46e.

Evaluation of Infectious Agents in the Pediatric Palliative Care Unit

Yıl 2024, Cilt: 3 Sayı: 4, 152 - 160, 20.12.2024
https://doi.org/10.57221/izmirtip.1494548

Öz

Aim: The use of broad-spectrum antibiotics, changes in patient profile, prolonged life expectancy, increased use of medical devices and technologies such as catheters, intravenous fluids, gastrostomy and tracheostomy have led to changes in the number and types of microorganisms isolated from infections and cultures. There are no data on infections seen in pediatric palliative care. The aim of this study was to determine the frequency of infections and the pathogens produced in culture, to identify the sites of growth and to review what should be done.
Materials and Methods: This was planned as a cross-sectional, retrospective study between 11/18/2018 and 09/01/2023. Sociodemographic data, reason for hospitalization, number of hospitalizations, primary diagnoses, comorbid conditions, medical devices and technology used, time and place of culture, number of cultures, microorganisms grown and factors associated with culture growth were examined. Statistical analysis was performed with the SPSS 18.0 program. p<0.05 was considered significant. Local ethics committee approval was obtained (14/09/2023-176).
Results: A total of 218 of 414 patients were included in the study. A total of 1209 culture examinations from 392 hospitalizations were evaluated. The mean age was 5.68±5.33 (SD) years, and 56.9% (n=124) were male. When the reasons for hospitalization were grouped as infection and non-infection, no difference was found in terms of culture growth (p=0.778). There was a significant difference between medical comorbidities and culture growth (p=0.008) and when evaluated by post hoc analysis, a significant difference was found in relation with cardiovascular diseases and congenital diseases (p=0.001 and p=0.018, respectively).
Conclusion: These results are the first data in pediatric palliative care and show that approximately half of the patients had culture growth and were associated with cardiovascular diseases and congenital diseases. For our patient profile requiring long-term treatment and follow-up, family education, care and education on the prevention of infections should be repeated at regular intervals to reduce the frequency of infection.

Kaynakça

  • 1. Ergul AB, Isık H, Altıntop YA, Torun YA. A retrospective evaluation of blood cultures in a pediatric intensive care unit: a three year evaluation. Turk Pediatri Ars. 2017;52:154-61.
  • 2. Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001;7:188-92.
  • 3. Gulmez D, Gur D. Microorganisms isolated from blood cultures in Hacettepe University Ihsan Dogramacı children’s hospital from 2000 to 2011: Evaluation of 12 Years. J Pediatr Inf. 2012;6:79-83.
  • 4. Saglam D, Ercal BD, Yagmur G, Oz HT, Akin MA, Berk E. Distribution of microorganisms isolated from blood cultures collected from the neonatal intensive care units of Kayseri training and research hospital. Abant Med J. 2015;4:255-60.
  • 5. Celiloglu C, Tolunay O, Celik T, Sucu T, Yurtcu E, Celik E. Assessment of healthcare-associated infections in the pediatric intensive care unit. J Pediatr Inf. 2017;11:129-34.
  • 6. Adamuz J, Viasus D, Camprecios-Rodriguez P, Canavate-Jurado O, Jimenez-Martinez E, Isla P, et al. A prospective cohort study of healthcare visits and rehospitalizations after discharge of patients with community-acquired pneumonia. Respirology. 2011;16:1119-26.
  • 7. Markham JL, Hall M, Goldman JL, Bettenhausen JL, Gay JC, Feinstein J, et al. Readmissions following hospitalization for infection in children with or without medical complexity. Journal of Hospital Medicine. 2021;16:134-41.
  • 8. Cetin S, Celik I, Artan C. Evaluation of microorganisms and antibiotic resistance profile isolated in intensive care unit patients. Turk J Intensive Care. 2021;19:9-17.
  • 9. Bayram A, Balci I. Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey. BMC Infect Dis. 2006;6:155.
  • 10. Erturk A, Copur C, Koksal E, Koksal Z, Ozyurt S. Microorganisms isolated from various clinical samples and their antibiotic susceptibilities in intensive care unit patients. ANKEM Derg. 2012;26:1-9.
  • 11. Atici S, Soysal A, Kadayifci KE, Karaaslan A, Akkoc G, Yakut N, et al. Healthcare-associated infections in a newly opened pediatric intensive care unit in Turkey: results of four-year surveillance. J Infect Dev Ctries. 2016;10:254-9.
  • 12. Aktar F, Tekin R, Gunes A, Ulgen C, Tan I, Ertugrul S, et al. Determining the independent risk factors and mortality rate of nosocomial infections in pediatric patients. Biomed Res Int. 2016; 7240864.
  • 13. Lopez AP, Ladhani SN, Breathnach A, Planche T, Helath PT. Trends in paediatric nosocomial bacteraemia in a London tertiary hospital. Acta Paediatr. 2013;102:1005-9.
  • 14. Wienecke LM, Cohen S, Bauersachs J, Mebazaa A, Chousterman BG. Immunity and inflammation: the neglected key players in congenital heart disease? Heart Fail Rew. 2022;27:1957-71.
  • 15. Furlong-Dillard J, Bailly D, Amula V, Wilkes J, Bratton S. Resource use and morbidities in pediatric cardiac surgery patients with genetic conditions. J Pediatr. 2018;193:139-46e.
Toplam 15 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Bebek ve Çocuk Sağlığı, Çocuk Sağlığı ve Hastalıkları (Diğer)
Bölüm Araştırma Makaleleri
Yazarlar

Nilgün Harputluoğlu 0000-0002-2662-6488

Yakup Yaman Bu kişi benim 0009-0001-9493-4650

Derşan Onur 0000-0002-8152-3043

Miray Yılmaz Bu kişi benim 0000-0002-3537-0664

Mustafa Gülderen Bu kişi benim 0000-0002-2227-1288

Tanju Çelik 0000-0003-3522-9406

Ünsal Yılmaz 0000-0002-7256-8557

Yayımlanma Tarihi 20 Aralık 2024
Gönderilme Tarihi 2 Haziran 2024
Kabul Tarihi 6 Kasım 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 3 Sayı: 4

Kaynak Göster

APA Harputluoğlu, N., Yaman, Y., Onur, D., Yılmaz, M., vd. (2024). Evaluation of Infectious Agents in the Pediatric Palliative Care Unit. İzmir Tıp Fakültesi Dergisi, 3(4), 152-160. https://doi.org/10.57221/izmirtip.1494548
AMA Harputluoğlu N, Yaman Y, Onur D, Yılmaz M, Gülderen M, Çelik T, Yılmaz Ü. Evaluation of Infectious Agents in the Pediatric Palliative Care Unit. İzmir Tıp Fak. Derg. Aralık 2024;3(4):152-160. doi:10.57221/izmirtip.1494548
Chicago Harputluoğlu, Nilgün, Yakup Yaman, Derşan Onur, Miray Yılmaz, Mustafa Gülderen, Tanju Çelik, ve Ünsal Yılmaz. “Evaluation of Infectious Agents in the Pediatric Palliative Care Unit”. İzmir Tıp Fakültesi Dergisi 3, sy. 4 (Aralık 2024): 152-60. https://doi.org/10.57221/izmirtip.1494548.
EndNote Harputluoğlu N, Yaman Y, Onur D, Yılmaz M, Gülderen M, Çelik T, Yılmaz Ü (01 Aralık 2024) Evaluation of Infectious Agents in the Pediatric Palliative Care Unit. İzmir Tıp Fakültesi Dergisi 3 4 152–160.
IEEE N. Harputluoğlu, Y. Yaman, D. Onur, M. Yılmaz, M. Gülderen, T. Çelik, ve Ü. Yılmaz, “Evaluation of Infectious Agents in the Pediatric Palliative Care Unit”, İzmir Tıp Fak. Derg., c. 3, sy. 4, ss. 152–160, 2024, doi: 10.57221/izmirtip.1494548.
ISNAD Harputluoğlu, Nilgün vd. “Evaluation of Infectious Agents in the Pediatric Palliative Care Unit”. İzmir Tıp Fakültesi Dergisi 3/4 (Aralık 2024), 152-160. https://doi.org/10.57221/izmirtip.1494548.
JAMA Harputluoğlu N, Yaman Y, Onur D, Yılmaz M, Gülderen M, Çelik T, Yılmaz Ü. Evaluation of Infectious Agents in the Pediatric Palliative Care Unit. İzmir Tıp Fak. Derg. 2024;3:152–160.
MLA Harputluoğlu, Nilgün vd. “Evaluation of Infectious Agents in the Pediatric Palliative Care Unit”. İzmir Tıp Fakültesi Dergisi, c. 3, sy. 4, 2024, ss. 152-60, doi:10.57221/izmirtip.1494548.
Vancouver Harputluoğlu N, Yaman Y, Onur D, Yılmaz M, Gülderen M, Çelik T, Yılmaz Ü. Evaluation of Infectious Agents in the Pediatric Palliative Care Unit. İzmir Tıp Fak. Derg. 2024;3(4):152-60.